Treatment

JNJ-86974680 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
This study is testing two new drugs, Pasritamig and JNJ-86974680, together for men with advanced prostate cancer. The main goal is to find the best and safest dose of these drugs when used in combination.
For: Prostatic Neoplasms
United States · United Kingdom